Lataa...
CRISPR-Cas9 Ribonucleoprotein-Mediated Genomic Editing in Primary Innate Immune Cells
CRISPR-Cas9 genome engineering can be used to functionally investigate the complex mechanisms of immune system regulation. Decades of work have aimed to genetically reprogram innate immunity, but current approaches are inefficient or nonspecific, limiting their use. Here, we detail an optimized stra...
Tallennettuna:
| Julkaisussa: | STAR Protoc |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7756923/ https://ncbi.nlm.nih.gov/pubmed/33377009 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.xpro.2020.100113 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|